Literature DB >> 22075982

Diverse p63 and p73 isoforms regulate Δ133p53 expression through modulation of the internal TP53 promoter activity.

V Marcel1, I Petit, F Murray-Zmijewski, T Goullet de Rugy, K Fernandes, V Meuray, A Diot, D P Lane, D Aberdam, J-C Bourdon.   

Abstract

In response to stress, p53 binds and transactivates the internal TP53 promoter, thus regulating the expression of its own isoform, Δ133p53α. Here, we report that, in addition to p53, at least four p63/p73 isoforms regulate Δ133p53 expression at transcriptional level: p63β, ΔNp63α, ΔNp63β and ΔNp73γ. This regulation occurs through direct DNA-binding to the internal TP53 promoter as demonstrated by chromatin immunoprecipitation and the use of DNA-binding mutant p63. The promoter regions involved in the p63/p73-mediated transactivation were identified using deleted, mutant and polymorphic luciferase reporter constructs. In addition, we observed that transient expression of p53 family members modulates endogenous Δ133p53α expression at both mRNA and protein levels. We also report concomitant variation of p63 and Δ133p53 expression during keratinocyte differentiation of HaCat cells and induced pluripotent stem cells derived from mutated p63 ectodermal dysplasia patients. Finally, proliferation assays indicated that Δ133p53α isoform regulates the anti-proliferative activities of p63β, ΔNp63α, ΔNp63β and ΔNp73γ. Overall, this study shows a strong interplay between p53, p63 and p73 isoforms to orchestrate cell fate outcome.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22075982      PMCID: PMC3321620          DOI: 10.1038/cdd.2011.152

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  41 in total

1.  DN-p73 is activated after DNA damage in a p53-dependent manner to regulate p53-induced cell cycle arrest.

Authors:  Stefania Vossio; Emanuele Palescandolo; Natalia Pediconi; Francesca Moretti; Clara Balsano; Massimo Levrero; Antonio Costanzo
Journal:  Oncogene       Date:  2002-05-23       Impact factor: 9.867

2.  p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities.

Authors:  A Yang; M Kaghad; Y Wang; E Gillett; M D Fleming; V Dötsch; N C Andrews; D Caput; F McKeon
Journal:  Mol Cell       Date:  1998-09       Impact factor: 17.970

3.  Primary structure polymorphism at amino acid residue 72 of human p53.

Authors:  G J Matlashewski; S Tuck; D Pim; P Lamb; J Schneider; L V Crawford
Journal:  Mol Cell Biol       Date:  1987-02       Impact factor: 4.272

4.  p53 directly transactivates Δ133p53α, regulating cell fate outcome in response to DNA damage.

Authors:  M Aoubala; F Murray-Zmijewski; M P Khoury; K Fernandes; S Perrier; H Bernard; A-C Prats; D P Lane; J-C Bourdon
Journal:  Cell Death Differ       Date:  2010-08-06       Impact factor: 15.828

5.  Heterozygous germline mutations in the p53 homolog p63 are the cause of EEC syndrome.

Authors:  J Celli; P Duijf; B C Hamel; M Bamshad; B Kramer; A P Smits; R Newbury-Ecob; R C Hennekam; G Van Buggenhout; A van Haeringen; C G Woods; A J van Essen; R de Waal; G Vriend; D A Haber; A Yang; F McKeon; H G Brunner; H van Bokhoven
Journal:  Cell       Date:  1999-10-15       Impact factor: 41.582

6.  Simple sequence repeat polymorphism within the p53 gene.

Authors:  V Lazar; F Hazard; F Bertin; N Janin; D Bellet; B Bressac
Journal:  Oncogene       Date:  1993-06       Impact factor: 9.867

Review 7.  p53 isoforms - a conspiracy to kidnap p53 tumor suppressor activity?

Authors:  V Marcel; P Hainaut
Journal:  Cell Mol Life Sci       Date:  2009-02       Impact factor: 9.261

8.  Human embryonic stem-cell derivatives for full reconstruction of the pluristratified epidermis: a preclinical study.

Authors:  Hind Guenou; Xavier Nissan; Fernando Larcher; Jessica Feteira; Gilles Lemaitre; Manoubia Saidani; Marcela Del Rio; Christine C Barrault; François-Xavier Bernard; Marc Peschanski; Christine Baldeschi; Gilles Waksman
Journal:  Lancet       Date:  2009-11-21       Impact factor: 79.321

9.  A pure population of ectodermal cells derived from human embryonic stem cells.

Authors:  Edith Aberdam; Efrat Barak; Matthieu Rouleau; Stephanie de LaForest; Sonia Berrih-Aknin; David M Suter; Karl-Heinz Krause; Michal Amit; Joseph Itskovitz-Eldor; Daniel Aberdam
Journal:  Stem Cells       Date:  2007-11-21       Impact factor: 6.277

Review 10.  p63 is a suppressor of tumorigenesis and metastasis interacting with mutant p53.

Authors:  G Melino
Journal:  Cell Death Differ       Date:  2011-07-15       Impact factor: 15.828

View more
  30 in total

1.  Influenza A viruses control expression of proviral human p53 isoforms p53β and Delta133p53α.

Authors:  Olivier Terrier; Virginie Marcel; Gaëlle Cartet; David P Lane; Bruno Lina; Manuel Rosa-Calatrava; Jean-Christophe Bourdon
Journal:  J Virol       Date:  2012-05-30       Impact factor: 5.103

2.  Impact of G-quadruplex structures and intronic polymorphisms rs17878362 and rs1642785 on basal and ionizing radiation-induced expression of alternative p53 transcripts.

Authors:  Laury Perriaud; Virginie Marcel; Charlotte Sagne; Vincent Favaudon; Aurore Guédin; Aurore De Rache; Corinne Guetta; Florian Hamon; Marie-Paule Teulade-Fichou; Pierre Hainaut; Jean-Louis Mergny; Janet Hall
Journal:  Carcinogenesis       Date:  2014-09-30       Impact factor: 4.944

3.  Modulation of p53β and p53γ expression by regulating the alternative splicing of TP53 gene modifies cellular response.

Authors:  V Marcel; K Fernandes; O Terrier; D P Lane; J-C Bourdon
Journal:  Cell Death Differ       Date:  2014-06-13       Impact factor: 15.828

4.  p73 regulates autophagy and hepatocellular lipid metabolism through a transcriptional activation of the ATG5 gene.

Authors:  Z He; H Liu; M Agostini; S Yousefi; A Perren; M P Tschan; T W Mak; G Melino; H U Simon
Journal:  Cell Death Differ       Date:  2013-08-02       Impact factor: 15.828

Review 5.  p53 Isoforms: Key Regulators of the Cell Fate Decision.

Authors:  Sebastien M Joruiz; Jean-Christophe Bourdon
Journal:  Cold Spring Harb Perspect Med       Date:  2016-08-01       Impact factor: 6.915

6.  Somatic and Germline TP53 Alterations in Second Malignant Neoplasms from Pediatric Cancer Survivors.

Authors:  Amy L Sherborne; Vincent Lavergne; Katharine Yu; Leah Lee; Philip R Davidson; Tali Mazor; Ivan V Smirnoff; Andrew E Horvai; Mignon Loh; Steven G DuBois; Robert E Goldsby; Joseph P Neglia; Sue Hammond; Leslie L Robison; Rosanna Wustrack; Joseph F Costello; Alice O Nakamura; Kevin M Shannon; Smita Bhatia; Jean L Nakamura
Journal:  Clin Cancer Res       Date:  2016-09-28       Impact factor: 12.531

7.  The p53 isoforms are differentially modified by Mdm2.

Authors:  Suzanne Camus; Sergio Ménendez; Kenneth Fernandes; Nelly Kua; Geng Liu; Dimitris P Xirodimas; David P Lane; Jean-Christophe Bourdon
Journal:  Cell Cycle       Date:  2012-04-15       Impact factor: 4.534

Review 8.  How Does p73 Cause Neuronal Defects?

Authors:  Maria Victoria Niklison-Chirou; Richard Killick; Richard A Knight; Pierluigi Nicotera; Gerry Melino; Massimiliano Agostini
Journal:  Mol Neurobiol       Date:  2015-08-13       Impact factor: 5.590

9.  Molecular dynamics of the full-length p53 monomer.

Authors:  Giovanni Chillemi; Pavel Davidovich; Marco D'Abramo; Tazhir Mametnabiev; Alexander Vasilievich Garabadzhiu; Alessandro Desideri; Gerry Melino
Journal:  Cell Cycle       Date:  2013-09-05       Impact factor: 4.534

10.  p63 threonine phosphorylation signals the interaction with the WW domain of the E3 ligase Itch.

Authors:  Sonia Melino; Alessia Bellomaria; Ridvan Nepravishta; Maurizio Paci; Gerry Melino
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.